Abstract
The experimental design for the evaluation of a single agent in cancer can be complex, and the results from different centers vary considerably. The variables involved in the evaluation of combinations of agents, as compared to single agents, increase substantially. Thus, in the construction of clinical trials involving combination chemotherapy, major emphasis should be given to the problem of experimental design.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Acute Leukemia Group B: Acute lymphocytic leukemia in children. Maintenance therapy with methotrexate administered intermittently. J. Amer. med. Ass. 207, 923–928 (1969).
Acute Leukemia Group B: Unpublished data (1970).
Alexanian, R.: Unpublished data of the Southwest Cancer Chemotherapy Study Group (1972).
Alexanian, R., Hart, A., Khan, A.U., Lane, M., MoKelvey, E.M., Miguore, P. J., Stuokey, W.J.Jr., Wilson, H.E.: Treatment for multiple myeloma; combination chemotherapy with different melphalan dose regimens. J. Amer. med. Ass. 208, 1680–1685 (1969).
Allaire, F.J., Thieme, E.T., Korst, D.R.: Cancer chemotherapy with 5-fluorouracil alone and in combination with X-ray therapy. Cancer Chemother. Rep. 14, 59–75 (1961).
Ansfield, F.J.: Further clinical comparison between 5-fluoro-2′-deoxyuridine (5-FUDR) and 5-fluorouracil (5-FU). Proc. Amer. Ass. Cancer Res. 4, 2 (1963).
Anspield, F. J., Ramirez, G., Korbitz, B.C., Daus, H.L., Jr.: Five drug therapy for advanced cancer: a phase I study. Cancer Chemother. Rep. 55, 183–188 (1971).
Bern ARD, J.: Acute leukemia treatment. Cancer Res. 27, 2565–2569 (1967).
Bernard, J., Boiron, M., Jaoquillat, E., Weill, M.: Rubidomycin: 400 patients with leukemia and other malignancies. Abstracts of the XII Congress of the Int. Society of Hemat., p. 5 (1968).
Bodey, G.P., Freireich, E.J.: Unpublished data of Southwestern Cancer Chemotherapy Study Group (1972).
Bodey, G.R., Luce, J.K., Harris, J.E., Frei, E., III: The effect of cytosine arabinoside on metastatic cancer and acute leukemia, p. 6. Abstracts of XII Congress, Inst. Soc. Hemat. (1968).
Bodey, G.P., Rodriguez, V., Whiteoar, J.P., Hart, J., Freireich, E.J.: The treatment of acute leukemia in adults. In: Leukemia-Lymphoma, a collection of papers presented at the 14 th annual clinical conference at M. D. Anderson Hospital and Tumor Institute pp. 333–346. Chicago: Yearbook Medical Publishers, Inc. 1970.
Bohannon, R.A., Miller, D.G., Diamond, H.: Vincristine in the treatment of lymphomas and leukemias. Cancer Res. 23, 613–621 (1963).
Bonnet, J.D., Brownlee, R.W.: Unpublished data of the Southwest Cancer Chemotherapy Study Group (1971).
Brennan, M.J., Talley, R.W., Sandiego, E.L., Burrows, J.H., O’Brien, R.M., Vaitkeviciks, V.M., Horeyland, S.: Critical analysis of 594 cancer patients treated with 5-fluorouracil. In: Plattner, P.A. (Ed.): Proceedings of the international symposium of chemotherapy of cancer, pp. 148–150. New York: American Elsevier 1964.
Burchenal, J.H.: Long term survivors in acute leukemia. In: Zarafonetis, C.J.D. (Ed.): Proceedings of the international conference on leukemia-lymphoma, pp. 469–474. Philadelphia: Lea Febiger 1968.
Burchenal, J.H., Dollinger, M.R.: Cytosine arabinoside (NSC-63878) in combination with 6-mercaptopurine (NSC-755), methotrexate (NSC-740) or fluorouracil (NSC-19893) in L1210 mouse leukemia. Cancer Chemother. Rep. 51, 435–438 (1967).
Calendi, E., DiMarco, A., Reggiani, M., Scarpinato, B., Valentini, L.: On physico-chemical interactions between daunomycin and nucleic acids. Biochim. biophys. Acta (Amst.) 103, 25–49 (1965).
Carter, S.: Clinical trials and combination chemotherapy. Cancer Chemother. Rep. 2, 81–97 (1971).
Coltman, C.A., Costanzi, J.J., Dudley, G.M., III., Haut, A., Lane, M., Gehan, E.A.: Further clinical studies of combination chemotherapy using cyclophosphamide, vincristine, methotrexate, and 5-fluorouracil. Amer. J. med. Sci. 261, 73–78 (1971).
Cooper, R.G.: Combination chemotherapy in hormone resistant breast cancer. Proc. Amer. Ass. Cancer Res. 10, 15 (1969).
Costanzi, J.J., Coltman, C.A.: Combination chemotherapy using cyclophosphamide, vincristine, methotrexate, and 5-fluorouracil. Cancer 23, 589–596 (1969).
Crowther, D., Bateman, C.J.T., Vartan, C.P., Whttehouse, J.M.A., Malpas, J.S., Fairley, G.H., Scott, R.B.: Combination chemotherapy using L-asparaginase, daunorubicin, and cytosine arabinoside in adults with acute myelogenous leukemia. Brit. med. J. 4, 513–517 (1970).
DeConti, R. C.: Procarbazine in the management of late Hodgkin’s disease. J. Amer. med. Ass. 215, 927–930 (1971).
Devita, V.T., Serpick, A.A., Carbone, P.P.: Combination chemotherapy in the treatment of advanced Hodgkin’s disease. Ann. intern. Med. 73, 881–895 (1970).
Djerassi, L. Romtnger, C.J., Kim, J., Turoui, J., Meyer, E.: Methotrexate — citrovorum in patients with lung cancer. Proc. Amer. Ass. Cancer Res. 11, 21 (1970).
Eastern Cooperative Group in Solid Tumor Chemotherapy: Comparison of antimetabolites in the treatment of breast and colon cancer. J. Amer. med. Ass. 200, 770–778 (1967).
Elion, G.B., Callahan, S.N., Nathan, H., Biebee, S., Bundles, R.W., Hitchings, G.M.: Potentiation of inhibition of drug degradation: 6-substituted purines and xanthine oxidase. Biochem. Pharmacol. 12, 85–93 (1963).
Ellison, R.R.: Experience with fluorinated pyrimidines in adenocarcinoma of the lower intestinal tract. N. Y. J. Med. 62, 2364–2369 (1962).
Ellison, R. R., Holland, J. F., Weil, M., Jacquillat, C., Boiron, M., Bernard, J., Sawttsky, A., Rosner, F., Gussott, B., Silver, R. T., Karamas, A., Cuttner, J., Spurr, C.L., Hayes, D.M., Blom, J., Leone, L.A., Maurani, F., Kyle, R., Hutchison, J.L., Forcier, R.J., Moon, J.N.: Arabinosyl cytosine: a useful agent in the treatment of acute leukemia in adults. Blood 32, 507–523 (1968).
Ezdinli, E.Z., Stutzman, L.: Vinblastine vs. nitrogen mustard therapy of Hodgkin’s disease. Cancer 22, 473–479 (1968).
Ezdinli, E.Z., Stutzman, L., Aungst, C.W., Firat, D.: Corticosteroid therapy for lymphomas and chronic lymphocytic leukemia. Cancer 23, 900–909 (1969).
Field, J.B.: 5-Fluorouracil (NCS 9893) treatment of advanced cancer in ambulatory patients. Cancer Chemother. Rep. 33, 45–49 (1963).
Frei, E., III.: Southwestern Chemotherapy Study Group data; manuscript in preparation, 1972.
Frei, E., III, DeVita, V.T., Moxley, J.N., Carbone, P.P.: Approaches to improving the chemotherapy of Hodgkin’s disease. Cancer Res. 26, 1284–1289 (1966).
Frei, E., III., Freireich, E.J.: Progress and perspectives in the chemotherapy of acute leukemias. Advanc. Chemother. 2, 269–298 (1965).
Frei, E., III., Freireich, E.J., Gehan, E., Pinley, D., Holland, J.F., Selawry, O., Haurami, F., Spurr, C.L., Hayes, D.M., Jones, G.W., Rothberg, H., Sodee, D.B., Runtles, R.W., Shroeder, L.R., Koogstraten, B., Wolman, I.J., Traggis, D.G., Cooper, T., Gerdel, B.R., Ebaugh, F., Taylor, R.: Studies of sequential and combination antmetabolite therapy in acute leukemia: 6-mercaptopurine and methotrexate, from the acute leukemia Group B. Blood 18, 431–454 (1961).
Frei, E., III., Karon, M., Levin, R.M., Freireich, E.J., Taylor, R.J., Mananian, J., Selawry, O., Holland, J.F., Noogstraten, B., Wolman, J.J., Abir, E., Sawitsky, A., Lee, S., Mills, S.D., Bürgert, E.O., Jr., Spurr, C.L., Patterson, R.B., Ebaugh, F.G., James, G.W., III., Moon, J.N.: The effectiveness of combinations of antileukemic agents in inducing and maintaining remission in children with acute leukemia. Blood 26, 642–656 (1965).
Freireich, E. J., Gehan, E., Frei, E., III, Schroeder, L.R., Wolman, I. J., Anbori, R., Bürgerte, O., Mills, S.D., Pinkel, D., Selawry, O.S., Moon, J.N., Gendel, B.R., Spurr, G.L., Storrs, R. Maurani, F., Noogstraten, B., Lee, S.: The effect of 6-mercaptopurine on the duration of steroid-induced remission in acute leukemia: A model for evaluation of other potentially useful therapy. Blood 21, 699–716 (1963).
Freireioh, E.J., Henderson, E.S., Karon, M.R., Frei, E., III.: The treatment of acute leukemia considered with respect to cell population kinetics. In: The proliferation and spread of neoplastic cells, pp. 441–452. Baltimore: Williams and Wilkins 1968.
Gaudin, D., Yielding, K.L., Stabler, A., Brown, J.: The effect of DNA repair inhibitors on the response of tumors treated with x-ray and alkylating agents. Proc. Soc. exp. Biol. (N. Y.) 137, 202–206 (1971).
Gee, T.S., Yu, K.P„ Clarkson, B.D.: Treatment of adult acute leukemia with arabinosyl cytosine and thioguanine. Cancer 23, 1019–1032 (1969).
Gottlieb, J. A., Serpick, A. A.: Prolonged intravenous methotrexate therapy in the treatment of acute leukemia and solid tumors. Cancer Res. 30, 2132–2138 (1970).
Henderson, E.S.: Combination chemotherapy of acute lymphocytic leukemia of childhood. Cancer Res. 27, 2570–2572 (1967).
Henderson, E.S.: Treatment of acute leukemia. Ann. intern. Med. 69, 628–629 (1968).
Henderson, E.S.: Treatment of acute leukemia. Semin. Hemat. 6, 271–319 (1969).
Henderson, E. S., Samaha, R.J.: Evidence that drugs in multiple combinations have materially advanced the treatment of human malignancies. Cancer Res. 29, 2272–2280 (1969).
Henderson, E.S., Serpick, A.A.: The effect of combination drug therapy and prophylactic oral antibiotic treatment in adult acute leukemia. Clin. Res. 15, 336 (1967).
Henderson, E.S., Serpick, A.A., Leventhal, B.G., Henry, P.: Cytosine arabinoside infusions in adult and childhood acute myelocytic leukemia. Proc. Amer. Ass. Cancer Res. 9, 29 (1968).
Hersh, E.M., Whttecar, J.P., Jr., MoCredie, K.B., Bodey, G.P., Freireich, E.J.: Chemotherapy, immunocompetence, immunosuppression and prognosis in acute leukemia. N. Engl. J. Med. 285, 1211–1216 (1971).
Holland, J.F.: Clinical studies of unmaintained remission in acute lymphocytic leukemia. In: The proliferation and spread of neoplastic cells, pp. 453–462. Baltimore: Williams & Wilkins 1968.
Holland, J.F., Glidewell, O.: Induction, consolidation, intensification, reinduction and maintenance chemotherapy of acute lymphocytic leukemia. Abstracts of the XII Congress, Int. Soc. Hemat., p. 9. 1968.
Hoogstraten, B.: Cyclophosphamide in acute leukemia. Cancer chemother. Rep. 16, 167–171 (1962).
Hurley, J. D.: Treatment of advanced cancer with 5-fluorouracil. Acta Un. int. Cancer. 20, 363–365 (1964).
Jacobs, E.M., Peters, F.C., Lttce, J.K., Zippin, C., Wood, D.A.: Mechlorethamine HCl and cyclophosphamide in the treatment of Hodgkin’s disease and the lymphomas. J. Amer. med. Ass. 203, 392–398 (1968).
Kaplan, H.S.: Long-term results of palliative and radical radiotherapy of Hodgkin’s disease. Cancer Res. 26, 1250–1252 (1966).
Karon, M., Freireich, E. J., Frei, E., III., Taylor, R., Wolman, I. J., Djerassi, I., Lee, S.L., Sawitsky, A., Hananian, J., Selawry, O., James, D., Jr., George, P., Patterson, R.B., Bttrgert I., Haurani, F.I., Oberfield, R.A., Macy, C.T., Hoogstraten, B., Blom, T.: The role of vincristine in the treatment of childhood acute leukemia. Clin. Pharmacol. Ther. 7, 332–339 (1966).
Kennedy, B. J.: Chemotherapy of colon cancer. Lancet 84, 131–133 (1964).
Kennedy, B. J.: Hormonal therapies in breast cancer: Androgens versus estrogens. In: Breast cancer early and late, pp. 381–386. Chicago: Yearbook Medical Publishers 1970.
Lefkowttz, E., Papac, R.J., Bertino, J.R.: Head and neck cancer. III. Toxicity of 24-hour infusions of methotrexate (NSC 740) and protection by leucovorin (NSC 3590) in patients with epidermoid carcinomas. Cancer Chemother. Rep. 51, 305–311 (1967).
Leiktn, J.L., Brubaker, C., Hartmann, J.R., Murphy, M.L., Wolff, J.A., Perrin, E.: Varying prednisone dosage in remission induction of previously untreated childhood leukemia. Cancer 21, 346–351 (1968).
LePage, G.A.: Unpublished data (1972).
LePage, G.A., Jones, M.: Further studies on mechanism of action of 6-thioguanine. Cancer Res. 21, 1590–1594 (1961).
Li, M. D., Whttmore, W.F., Jr., Golbey, R., Gragstald, M.: Effects of combined drug therapy on metastatic cancer of the testis. J. Amer. med. Ass. 174, 1291–1301 (1960).
Liegler, D.G., Henderson, E.S., Hahn, M.A., Oliverio, V.T.: The effect of organic acids on renal clearance of methotrexate in man. Clin. Pharmacol. Ther. 10, 849–857 (1969).
Livingston, R., Carter, S.: Single agents in cancer chemotherapy. New York: Plenum 1970.
Livingston, R.B., Venditti, J.M., Cooney, D.A., Carter, S.K.: Glutamine antagonists in chemotherapy. Advanc. Pharmacol. Chemother. 8, 57–120 (1970).
Luce, J.K., Gamble, J.F., Wilson, N.E., Monto, R.W., Isaacs, B.L., Palmer, R.L., Coltman, CA., Jr., Hewlett, J. S., Gehan, E.A., Frei, E., III: Combined cyclophosphamide, vincristine and prednisone therapy of malignant lymphoma. Cancer 28, 306–317 (1971).
MacKenzie, A.R.: Chemotherapy of metastatic testis cancer. Results in 154 patients. Cancer 19, 1369–1376 (1966).
Mass, R.E.: A comparison of the effect of prednisone and a placebo in the treatment of multiple myeloma. Cancer Chemother. Rep. 16, 257–259 (1962).
Mellett, L.B., El Da Reer, S.M., Luce, J.K., Frei, E., III.: Activation of cyclophosphamide in various species. Pharmacologist 11, 273 (1969).
Middleman, E., Luce, J. K., Frei, E., III.: Clinical trials with adriamycin. Cancer 28, 844–850 (1971).
Mitchell, M.S., Wawro, N.W., DeConti, R.C., Kaplan, S.R., Papac, R., Berttno, J.R.: Effectiveness of high dose infusions of methotrexate followed by leucovorin in carcinoma of the head and neck. Cancer Res. 28, 1088–1094 (1968).
Moertel, C.G., Reitemeier, R.J., Kahn, R.G.: Therapy with the fluorinated pyrimidines. In: Moertel, C.G., Reitemeier, R.J. (Eds.): Advanced gastrointestinal cancer. Clinical management and chemotherapy, pp. 86–107. New York: Harper & Row 1969.
Nathanson, L., Hall, T.C., Schilling, A., Miller, S.: Concurrent combination chemotherapy of human solid tumors: experience with a three-drug regimen and review of the literature. Cancer Res. 29, 419–425 (1969).
Piessens, W.F., Keimann, R., Legrtts, N., Kettson, J.C.: Effect of BCG on mammary tumor formulation and cellular immunity in DMBA-treated rats. Cancer Res. 31, 1061–1065 (1971).
Pinkel, D., Hernandez, K., Borella, L., Holton, C., Aur, R., Samoy, G., Pratt, C.: Drug dosage and remission duration in childhood lymphocytic leukemia. Cancer 27, 247–256 (1971).
Pinkel, D., Pratt, C., Holton, C., James, D., Jr., Wrenn, E., Jr., Hustu, H.O.: Survival of children with neuroblastoma treated with combination chemotherapy. J. Pediat. 73, 928–931 (1968).
Preisler, H.D., Henderson, E.S.: Effect of cytosine arabinoside and l, 3-bis-2-chloroethyl-1-nitrosourea on hematopoietic precursors in the mouse. J. nat. Cancer Inst. 47, 971–977 (1971).
Rochlin, D.B., Shiner, J., Langdon, E., Ottoman, R.: Use of 5-fluorouracil in disseminated solid neoplasms. Ann. Surg. 156, 105–113 (1962).
Salmon, S.E.: Personal communication (1972).
Salmon, S.E., Smith, B.A.: Immunoglobulin synthesis and total body tumor cell number in IgG multiple myeloma. J. clin. Invest. 49, 1114–1121 (1970).
Sartorelli, A.C., Creasey, W.A.: Combination chemotherapy. In: Holland, J.F., Frei, E., III. (Eds.): Cancer medicine. Philadelphia: Lea & Febiger 1973.
Schneck, S.A., Penn, J.: De Novo brain tumours in renal transplant recipients. Lancet 1, 983–986 (1971).
Scott, J. L.: The effect of nitrogen mustard and maintenance chlorambucil in the treatment of advanced Hodgkin’s disease. Cancer Chemother. Rep. 27, 27–32 (1963).
Selawry, O.S.: New treatment schedule with improved survival in childhood leukemia: Intermittent parenteral daily oral administration of methotrexate for maintenance of induced remission. J. Amer. med. Ass. 194, 75–81 (1965).
Sharp, G. S., Benefiel, W.W.: 5-Fluorouracil in the treatment of inoperable carcinoma of the colon and rectum. Cancer Chemother. Rep. 20, 97–101 (1962).
Skipper, H.E., Schabel, F.M., Trader, M.W., Laster, W.R., Simpson, L., Lloyd, M.M.: Basic and therapeutic trial results obtained in the spontaneous AKR leukemia (lymphoma) model. Cancer Chemother. Rep. (in press).
Skipper, H.E., Schabel, F.M., Jr., Wilcox, W.S.: Experimental evaluation of potential anticancer agents. XXI. Scheduling of arabinosyl cytosine to take advantage of its 5-phase specificity against leukemia cells. Cancer Chemother. Rep. 51, 125–141 (1967).
Spear, P., Patno, M.: A comparative study of the effectiveness of HN2 and cyclophosphamide in bronchogenic carcinoma, Hodgkin’s disease and lymphosarcoma. Cancer Chemother. Rep. 16, 413–415 (1962).
Ultmann, J.E., Nixon, D.D.: The therapy of lymphoma. Semin. hemat. 6, 376–403 (1969).
Venditti, J.M., Humphreys, S.R., Mantel, N., Goldin, A.: Combined treatment of advanced leukemia (L1210) in mice with amethopterin and 6-mercaptopurine. J. nat. Cancer. Inst. 17, 631–638 (1956).
Weiss, A.J., Jackson, L.: The effect of 5-fluorouracil upon carcinomas of the gastrointestinal tract and related organs. Amer. J. Gastroent. 35, 138–146 (1961).
Whang-Peng, C.P., Knutsen, T.: Polyploidy in malignant melanoma. Cancer 25, 1216–1223 (1970).
Whtteoar, J.P., Jr., Bodey, G.P., Freireich, E.J.: Combination chemotherapy (COAP) of adult acute leukemia. Proc. Amer. Ass. Cancer Res. 11, 83 (1970).
Wolff, J. A., Brubaker, C.A., Murphy, M.L., Pierce, M. I., Severo, N.: Prednisone therapy of acute childhood leukemia: Prognosis and duration of response in 330 treated patients. J. Pediat. 70, 626–631 (1967).
Zuelzer, W.W.: Implications of long-term survival in acute stem cell leukemia of childhood treated with composite cyclic therapy. Blood 24, 477–494 (1964).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1974 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Frei, E., Gottlieb, J.A. (1974). Combination Chemotherapy: Clinical Considerations. In: Sartorelli, A.C., Johns, D.G. (eds) Antineoplastic and Immunosuppressive Agents Part I. Handbuch der experimentellen Pharmakologie / Handbook of Experimental Pharmacology, vol 38 / 1. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-65678-1_21
Download citation
DOI: https://doi.org/10.1007/978-3-642-65678-1_21
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-65680-4
Online ISBN: 978-3-642-65678-1
eBook Packages: Springer Book Archive